Company Highlight

Technology and science

Useful Information


Oncovita is a preclinical stage biotech company pioneering the development of oncolytic viruses to address unmet medical need. Led by a world-class management team with significant experience in the biotech industry, Oncovita is developing a pipeline therapy candidates based on its proprietary platform MeasoVirTM with the goal of delivering safe and efficient therapies against hematological cancers and solid tumors, faster and at greater scale to more patients.

28 rue Docteur Roux, 75015 Paris, France.